Trial Profile

A phase 3, randomized, observer-blind, multi-center study to compare the safety and immunogenicity of one dose of Novartis meningococcal ACWY conjugate vaccine with one dose of licensed meningococcal ACWY conjugate vaccine administered to healthy children 2-10 years of age.

Status: Completed

Phase of Trial: Phase III

Latest Information Update: 18 Feb 2016

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Meningococcal vaccine groups A C Y W-135 conjugate (Primary)
Indications Meningococcal group A infections; Meningococcal group C infections; Meningococcal group W-135 infections; Meningococcal group Y infections
Focus Adverse reactions; Pharmacodynamics

30 Aug 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
30 Aug 2010 Actual initiation date changed from Feb 2008 to Mar 2008 as reported by ClinicalTrials.gov.
30 Aug 2010 Actual end date (Oct 2009) added as reported by ClinicalTrials.gov.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com